Search

everythinglearnresearchcommunity

for

Search:↓

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

A man in Japan got better from a scalp fungal infection using terbinafine.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Astrotactin2 affects hair follicle orientation and skin cell polarity.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Immune cells are crucial for hair growth and preventing hair loss.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Alopecia areata involves immune response and gene changes affecting hair loss.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.